Cafepharma Today

April 23 2024 - Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint
Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint
Big Pharma market caps surge to start 2024 despite economic headwinds
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Novartis names ex-BMS CEO Caforio as chair amid strong Q1
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Vical Will Keep Plunging
Motley Fool
Saturday, December 22, 2012 - 12:27pm
tags:
Vical
Does Qsymia Have a Future After All?
Wall Street Cheat Street
Saturday, December 22, 2012 - 12:26pm
tags:
Qsymia, weight loss, obesity, Vivus
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, December 22, 2012 - 12:25pm
tags:
Oncothyreon, Amicus Therapeutics, Herbalife
Why Cerus Is Poised to Plunge
Motley Fool
Saturday, December 22, 2012 - 12:24pm
tags:
Cerus
Upcoming FDA Decision For AVEO's Tivozanib Builds Speculation
Seeking Alpha
Saturday, December 22, 2012 - 12:23pm
tags:
Aveo Pharmaceutical, tivozanib, ONYX Pharmaceuticals
4 Investing Lessons From Questcor's 2012
Motley Fool
Saturday, December 22, 2012 - 12:22pm
tags:
Questcor Pharmaceuticals
Buy Galena Biopharma Now
Seeking Alpha
Saturday, December 22, 2012 - 12:21pm
tags:
Galena Biopharma
NPS Gattex Wins Approval for Short-Bowel Syndrome
Bloomberg
Saturday, December 22, 2012 - 12:19pm
tags:
Gattex, short bowel syndrome, NPS Pharmaceuticals
Halozyme Jumps Most in Six Years on Pfizer Partnership
Bloomberg
Saturday, December 22, 2012 - 12:17pm
tags:
Halozyme, Pfizer
Gilead A Strong Buy On New HIV Treatments
Motley Fool
Saturday, December 22, 2012 - 12:16pm
tags:
Gilead, HIV, Stribild
Long Mannkind? How To Make Money While In Queue
Seeking Alpha
Saturday, December 22, 2012 - 12:15pm
tags:
MannKind
Transcept caps a tough year with PhII drug failure
Fierce Biotech
Friday, December 21, 2012 - 10:56am
tags:
Transcept, TO-2061, OCD
5 Drug Hopefuls That Are Going to Change Your Life: Part 5
Motley Fool
Friday, December 21, 2012 - 10:54am
tags:
LAMA/LABA, GSK, Theravance, COPD
Cubist Submits ENTEREG Supplemental NDA
Yahoo
Friday, December 21, 2012 - 10:52am
tags:
Entereg, Cubist Pharmaceuticals, bowel resection
3 Things to Watch at Isis Pharmaceuticals
Motley Fool
Friday, December 21, 2012 - 10:49am
tags:
Isis Pharmaceuticals, Kynamro
Medicines Co skin infection antibiotic meets trial goal
Reuters
Friday, December 21, 2012 - 10:46am
tags:
antibiotics, Medicines Company, Solo-1
Teva's New Focused Corporate Strategy Is Just What The Doctor Ordered
Seeking Alpha
Friday, December 21, 2012 - 10:45am
tags:
Teva
Smaller players looking for expansion deals, too
Fierce Pharma
Friday, December 21, 2012 - 10:45am
tags:
M&A, Stallergenes
How will pharma fare in 2013? It's complicated
Fierce Pharma
Friday, December 21, 2012 - 10:44am
tags:
pharma industry
Pfizer Pays $1M For Violating Deal With Oregon
Pharmalot
Friday, December 21, 2012 - 10:43am
tags:
Pfizer, settlements, Oregon, drug ads

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers
Drug Channels
The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels

Latest Jobs

Account Executive - Hospice
Kansas City, MO, 64113
Agape Care Group
Account Executive - Hospice
Buckner, MO, 64016
Agape Care Group
Account Executive - Hospice
Wellington, MO, 64097
Agape Care Group
Account Executive - Hospice
Independence, MO, 64057
Agape Care Group
Account Executive - Hospice
Kansas City, MO, 64158
Agape Care Group
Account Executive - Hospice
Kansas City, MO, 64119
Agape Care Group
Account Executive - Hospice
Raymore, MO, 64083
Agape Care Group
Account Executive - Hospice
Kansas City, MO, 64120
Agape Care Group
Account Executive - Hospice
Archie, MO, 64725
Agape Care Group
Account Executive - Hospice
Mayview, MO, 64071
Agape Care Group
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information